Lupin shuts manufacturing plant after 17 staff test Covid-19 positive

Topics Lupin | Coronavirus | Lockdown

Employees from one of the plants, which produces tuberculosis drugs, have tested positive in recent days.
Drugmaker Lupin has shut one of its manufacturing plants in Gujarat after at least 17 employees at the site tested positive for Covid-19, two government officials said on Tuesday.

Lupin, one of India’s top five drugmakers, did not immediately respond to requests for comment. The firm has some 11 manufacturing plants at the Ankleshwar site in Gujarat state, which is spread out over 40 acres and has 984 employees, according to the company website.

Employees from one of those plants, which produces tuberculosis drugs, have tested positive in recent days, said M D Modia, a senior district official. “The plant was shut on July 12 after the cases were confirmed,” said Modia, adding that the site has since been sanitized. “No cases have been reported from the other plants in the facility and their operations are unaffected,” he said. 




Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel